Ifinatamab Deruxtecan
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for Ifinatamab Deruxtecan, covering 2026-01-12 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Trial of Ifinatamab Deruxtecan in People With Advanced Esophageal Cancer (MK-3475-06F) [Phase 1, Phase 2]